Overcrowding in refugee camps, mistrust of authorities including vaccination registration processes, and lack of access to vaccines are some of the most pressing problems preventing migrants, refugees and other “uprooted people” from getting COVID-19 vaccines. A diverse, but also common set of issues are faced in refugee camps, informal settlements that house an estimated 79.5 […] Continue reading ->
India’s COVID crisis has laid bare the health costs of inadequate access to medical oxygen supplies – faced by many other countries even before India’s pandemic surge began.  Already in February, WHO said that oxygen shortages to treat those seriously ill were impacting more than half a million people in low- and middle-income countries every […] Continue reading ->
The World Health Organization (WHO) has decided to classify the B1.617 variant first identified in India as a “variant of concern”, according to Maria Van Kerkhove, WHO lead on COVID-19. “There is some available information to suggest increased transmissibility of B1.617,” Van Kerkhove explained to the WHO’s biweekly media briefing on Monday. In addition, a […] Continue reading ->
In a far-reaching statement, WHO and the International Coalition of Medicines Regulatory Authorities (ICMRA) called on the pharma industry to provide much wider access to clinical data for all new medicines and vaccines approved, or under review, and even those that had been rejected.  “Clinical trial reports should be published without redaction of confidential information […] Continue reading ->
The Chinese-made Sinopharm vaccine became the latest COVID-19 vaccine to receive an Emergency Use Listing from the World Health Organization (WHO) on Friday; experts said the vaccine showed an overall efficacy rate of 79% in preventing symptomatic and serious disease.  The WHO approval positions Sinopharm to become a major player in the COVAX global facility. […] Continue reading ->